Ausgabe 5/2022
Inhalt (6 Artikel)
Hypertension: Potential Player in Cardiovascular Disease Incidence in Preeclampsia
Parya Amini, Mehran Amrovani, Zohre Saleh Nassaj, Parisa Ajorlou, Aiyoub Pezeshgi, Bahareh Ghahrodizadehabyaneh
Cardiac Expression of Esophageal Cancer-Related Gene-4 is Regulated by Sp1 and is a Potential Early Target of Doxorubicin-Induced Cardiotoxicity
Dandan Long, Chunyue Chen, Wei Li, Wanling Peng, Dongmei Li, Rui Zhou, Xitong Dang
Upregulation of Uric Acid Production and Caspase 3 Signalling Mediates Rohypnol-Induced Cardiorenal Damage
R. E. Akhigbe, A. A. Oladipo, P. A. Oyedokun, M. A. Hamed, L. O. Okeleji, A. F. Ajayi
Exploring the Pattern of Metabolic Alterations Causing Energy Imbalance via PPARα Dysregulation in Cardiac Muscle During Doxorubicin Treatment
Kaviyarasi Renu, Sathishkumar Vinayagam, Harishkumar Madhyastha, Radha Madhyastha, Masugi Maruyama, Shubhankar Suman, Sankarganesh Arunachalam, Balachandar Vellingiri, Abilash Valsala Gopalakrishnan
Open Access
Overexpression of Programmed Cell Death 1 Prevents Doxorubicin-Induced Apoptosis Through Autophagy Induction in H9c2 Cardiomyocytes
Syu-ichi Kanno, Akiyoshi Hara
Open Access
Exogenous H2S Ameliorates High Salt-Induced Hypertension by Alleviating Oxidative Stress and Inflammation in the Paraventricular Nucleus in Dahl S Rats
Yingying Liao, Yuanyuan Fan, Qinglin He, Yuwei Li, Dongdong Wu, Enshe Jiang